SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001193125-21-131491
Filing Date
2021-04-26
Accepted
2021-04-26 16:11:57
Documents
1
Effectiveness Date
2021-04-26

Document Format Files

Seq Description Document Type Size
1 15-12B d170277d1512b.htm 15-12B 10286
  Complete submission text file 0001193125-21-131491.txt   11401
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-36070 | Film No.: 21853936
SIC: 2834 Pharmaceutical Preparations